PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Exicure, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Exicure, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 93% of Healthcare companies in United States.
  • Tangible Assets Ratio: Of every $100 the company owns, $42 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 87% of Healthcare companies in United States.
  • Shareholder Slice Ratio: Share count rose 542% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 87% of Healthcare companies in United States.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

1/3 · 2/3

Sales grew in 1 of the last 3 years; profit grew in 2 of 3.

Steadier than 50% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales fell 100%

Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

-100% / -40%

In 3 years sales changed by -100% while total assets changed by -40%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

-48.6×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 72% of Healthcare companies in United States.

Cash Cushion Ratio

+48%

Cash, after subtracting all debt, equals 48% of its market value (net cash).

Higher than 77% of Healthcare companies in United States.

Tangible Assets Ratio

42%

Of every $100 the company owns, $42 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 87% of Healthcare companies in United States.

Tangible Net Worth Ratio

Negative

Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.

Less tangible than 93% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+542%

Share count rose 542% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 87% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (11)

Exicure, Inc. made a loss over the last year. Exicure, Inc. owes $0.91 for every $1 it owns. Exicure, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Exicure, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

7.57

The share price is 7.57 times Exicure, Inc.'s book value per share, higher than 81% of Healthcare companies in United States.

Market cap

$7 M

The total market value of all of Exicure, Inc.'s shares at today's price (share price × number of shares), smaller than 90% of Healthcare companies in United States. PosiCap size class: Nano Cap.

Net worth (book value)

$1 M

What Exicure, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$0.15

Net worth divided by the number of shares. The share price of $1.13 is 7.6 times this, which is the P/B above.

Return on equity (ROE)

-168.4%

Exicure, Inc. lost 168.4% of its shareholders' money over the last year, lower than 81% of Healthcare companies in United States.

Owes vs Owns

0.91×

Exicure, Inc. owes $0.91 for every $1 it owns (high), higher than 84% of Healthcare companies in United States.

Dividend yield

None

Exicure, Inc. does not currently pay a dividend.

Profit growth

Loss

Exicure, Inc. made a loss in each of the last two years.

Interest cover

Not covered

Exicure, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net cash

Exicure, Inc. held $4 M more cash than debt (net cash) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Exicure, Inc.: $7 M ÷ $1 M (30 Jun 2026) = 7.6.

What is Exicure, Inc.'s return on equity?

Exicure, Inc. lost 168.4% of its shareholders' money over the last year, lower than 81% of Healthcare companies in United States.

How much does Exicure, Inc. owe compared with what it owns?

Exicure, Inc. owes $0.91 for every $1 it owns (high), higher than 84% of Healthcare companies in United States.

Does Exicure, Inc. pay a dividend?

No. Exicure, Inc. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.